Ochratoxin A and Human Health Risk: A Review of the Evidence

Critical Reviews in Food Science and Nutrition

Volumn 55, Issue 13, 2015, Pages 1860-1869

  Bui Klimke, Travis R ^a   Wu, Felicia ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

human health risks; Ochratoxin A; odds ratios; risk assessment; systematic review

Indexed keywords

DISEASES; HEALTH; RISK ASSESSMENT;

ADVERSE HEALTH EFFECTS; ASPERGILLUS OCHRACEUS; EPIDEMIOLOGICAL STUDIES; HUMAN HEALTH EFFECTS; HUMAN HEALTH RISKS; OCHRATOXIN A; ODDS RATIOS; SYSTEMATIC REVIEW;

HEALTH RISKS;

ANIMALIA; ASPERGILLUS OCHRACEUS; PENICILLIUM VERRUCOSUM;

OCHRATOXIN;

ANALYSIS; BALKAN NEPHROPATHY; EVIDENCE BASED MEDICINE; FOOD CONTAMINATION; FOOD CONTROL; HUMAN; NEPHROTIC SYNDROME; PATHOLOGY; RISK ASSESSMENT;

BALKAN NEPHROPATHY; EVIDENCE-BASED MEDICINE; FOOD CONTAMINATION; FOOD MICROBIOLOGY; HUMANS; NEPHROTIC SYNDROME; OCHRATOXINS; RISK ASSESSMENT;

EID: 84929868902     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2012.724480     Document Type: Article

References (72)

1. S.Abid,, W.Hassen,, A.Achour,, H.Skhiri,, K.Maaroufi,, F.Ellouz,, E.Creppy, and H.Bacha, (2003). Ochratoxin A and chronic human nephropathy in Tunisia: is the situation endemic? Hum. Exp. Toxicol. 22:77–84.
2. J.Ahn,, D.Kim,, H.Kim, and K.Y.Jahng, (2010). Quantitative determination of mycotoxins in urine by LC-MS/MS. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk. Assess. 27:1674–1682.
3. R.J.Baker, and C.D.Pusey, (2004). The changing profile of acute tubulointerstitial nephritis. Nephrol. Dial. Transplant. 19:8–11.
4. J.M.Barnes,, P.K.Austwick,, R.L.Carter,, F.V.Flynn,, G.C.Peristianis, and W.N.Aldridge, (1977). Balkan (endemic) nephropathy and a toxin-producing strain of Penicillium verrucosum var cyclopium: An experimental model in rats. Lancet. 1:671–675.
5. G.S.Bondy, and J.J.Pestka, (2000). Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B Crit. Rev. 3:109–143.
6. A.Breitholtz-Emanuelsson,, F.Minervini,, K.Hult, and A.Visconti, (1994). Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Natural. Toxins. 2:366–370.
7. M.Castegnaro,, D.Canadas,, T.Vrabcheva,, T.Petkova-Bocharova,, I.N.Chernozemsky, and A.Pfohl-Leszkowicz, (2006). Balkan endemic nephropathy: Role of ochratoxins A through biomarkers. Mol. Nutr. Food. Res. 50:519–529.
8. M.Castegnaro,, V.Maru,, G.Maru, and M.D.Ruiz-Lopez, (1990). High-performance liquid chromatographic determination of ochratoxin A and its 4R-4-hydroxy metabolite in human urine. Analyst. 115:129–131.
9. M.B.Coronel,, S.Marin,, M.Tarrago,, G.Cano-Sancho,, A.J.Ramos, and V.Sanchis, (2011). Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain. Food. Chem. Toxicol. 49:1436–1442.
10. A.Dahlmann,, W.H.Dantzler,, S.Silbernagl, and M.Gekle, (1998). Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: the nephrotoxin can be reabsorbed in all nephron segments by different mechanisms. J. Pharmacol. Esp. Ther. 286:157–162.
11. A.M.Domijan,, M.Peraica,, K.Markov, and R.Fuchs, (2009). Urine ochratoxin A and sphinganine/sphingosine ratio in residents of the endemic nephropathy area in Croatia. Arh. Hig. Rada. Toksikol. 60:387–393.
12. S.C.Duarte,, J.M.Bento,, A.Pena, and C.M.Lino, (2009). Ochratoxin A exposure assessment of the inhabitants of Lisbon during winter 2007/2008 through bread and urine analysis. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk Assess. 26:1411–1420.
13. S.Duarte,, J.Bento,, A.Pena,, C.M.Lino,, C.Delerue-Matos,, T.Oliva-Teles,, S.Morais,, M.Correia,, M.B.Oliveira,, M.R.Alves, and J.A.Pereira, (2010a). Monitoring of ochratoxin A exposure of the Portuguese population through a nationwide urine survey—Winter 2007. Sci. Total. Environ. 408:1195–1198.
14. S.C.Duarte,, A.Pena, and C.M.Lino, (2010b). Ochratoxin A in Portugal: a review to assess human exposure. Toxins. (Basel). 2:1225–1249.
15. S.C.Duarte,, A.Pena, and C.M.Lino, (2011). Human ochratoxin A biomarkers—From exposure to effect. Cr. Rev. Toxicol. 41:187–212.
16. F.Elling, (1979). Ochratoxin A-induced mycotoxic porcine nephropathy: alterations in enzyme activity in tubular cells. Acta Pathol. Microbiol. Scand. 87:237–243.
17. F.Elling, and P.Krogh, (1977). Fungal toxins and Balkan (endemic) nephropathy. Lancet. 1:1213.
18. European Food Safety Authority (EFSA). (2006). Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food. The EFSA Journal 365:1–56.
19. B.Fazekas,, A.Tar, and M.Kovacs, (2005). Ochratoxin a content of urine samples of healthy humans in Hungary. Acta Vet. Hung. 53:35–44.
20. J.Gilbert,, P.Brereton, and S.MacDonald, (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit. Contam. 18:1088–1093.
21. M.Godin,, A.Francois,, M.Le Roy,, J.-P.Morin,, E.Creppy,, J.Hemet, and J.P.Fillastre, (1996). Karyomegalic interstitial nephritis. Am. J. Kidney Dis. 27:166.
22. A.P.Grollman,, S.Shibutani,, M.Moriya,, F.Miller,, L.Wu,, U.Moll,, N.Suzuki,, A.Fernandes,, T.Rosenquist,, Z.Medverec,, K.Jakovina,, B.Brdar,, N.Slade,, R.J.Turesky,, A.K.Goodenough,, R.Rieger,, M.Vukelic, and B.Jelakovic, (2007). Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. U S A. 104:12129–12134.
23. S.Hagelberg,, K.Hult, and R.Fuchs, (1989). Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 9:91–96.
24. L.A.Haighton,, B.S.Lynch,, B.A.Magnuson, and E.R.Nestmann, (2012). A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model. Cr. Rev. Toxicol. 42:147–168.
25. W.Hassen,, S.Abid,, A.Achour,, E.Creppy, and H.Bacha, (2004). Ochratoxin A and beta2-microglobulinuria in healthy individuals and in chronic interstitial nephrppathy patients in the centre of Tunisia: a hot spot of Ochratoxin A exposure. Toxicology. 199:185–193.
26. Health Canada. (2009). Information document on health Canada's proposed maximum limits (standards) for the presence of the mycotoxin Ochratoxin A in foods. B.O.C.Safety, B. o. C. Ed., Ottawa. www.hc-sc.gc.ca/fn-an/consult/limits-max-seuils/myco_consult_ochra-eng.php.
27. IARC (1993). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Naturally. pp. 489–521. Taylor & Francis, Lyon.
28. A.M.Jimenez,, A.Lopez de Cerain,, E.Gonzalez-Penas,, J.Bello,, A.M.Betebeder, and E.E.Creppy, (1998). Exposure to ochratoxin A in Europe: comparison with a region of northern Spain. J. Toxicol.-Toxin Rev. 17:479–491.
29. Joint FAO/WHO Committee On Food Additives (JECFA). (1991). Evaluation of certain food additives and contaminants (Thirty-seventh report) In: WHO Technical Report Series. World Health Organization, Geneva, Switzerland.
30. Joint FAO/WHO Committee On Food Additives (JECFA). (2001). Safety Evaluations of Certain Mycotoxins in Food. In: JECFA Food Additives Series. Food and Agriculture Organization, Rome, Italy.
31. Joint FAO/WHO Committee On Food Additives (JECFA). (2007). Evaluation of certain food additives and contaminants (Sixty-eighth report) of the Joint FAO/WHO Expert Committee on Food Additives. In: WHO Technical Report Series. World Health Organization, Geneva, Switzerland.
32. F.E.Jonsyn-Ellis, (2001). Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girls. Mycopathologia. 152:35–40.
33. K.Jørgensen,, G.Rasmussen,, and I.Thorup, (1996). Ochratoxin A in Danish cereals 1986–1992. Food Addit. Contam. 13:95–104.
34. O.Kawamura,, S.Maki,, S.Sato,, and Y.Ueno, (1993). Ochratoxin A in livestock and human sera in Japan quantified by a sensitive ELISA. In: Human ochratoxicosis and its pathologies, pp. 123–127. E.E.Creppy, M.Castegnaro and G.Dirheimer, Eds. Montrouge, France: John Libbey Eurotext.
35. A.Khalef,, C.Zidane,, A.Charef,, A.Gharbi,, M.Tadjerouna,, A.M.Betbeder, and E.E.Creppy, (1993). Ochratoxicose humaine en Algerie. In: Human Ochratoxicosis and its Pathologies, pp. 167–174. E.E.Creppy, M.Castegnaro, G.Dirheimer, Eds, Montrouge, France: John Libbey Eurotext.
36. P.Krogh, (1974). Mycotoxic porcine neprophathy: A possible model for Balkan endemic nephropathy. In: Endemic Nephropathy, Sofia, Bulgaria. Publishing House of the Bulgarian Academy of Science, pp. 266–270. A.Puhlev,, Ed.
37. T.Kuiper-Goodman, (2004). Risk assessment and risk management of mycotoxins in food. In: Mycotoxins in Food. Detection and Control, pp. 3–31. N.Magan, M.Olsen, Eds., Taylor & Francis, Boca Raton,FL.
38. T.Kuiper-Goodman,, C.Hilts,, S.M.Billiard,, Y.Kiparissis,, I.K.Richard, and S.Hayward, (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit. Contam. 27:212–240.
39. T.Kuiper-Goodman, and P.M.Scott, (1989). Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 2:179–248.
40. Y.Liu,, C.C.Chang,, G.M.Marsh, and F.Wu, (2012). Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis. Eur. J. Cancer. 48:2125 –2136.
41. Y.Liu, and F.Wu, (2010). Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Env Health Perspec. 118: 818–824.
42. K.Maaroufi,, A.Achour,, A.M.Betbeder,, M.Hammami,, F.Ellouz,, E.E.Creppy, and H.Bacha, (1995). Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch. Toxicol. 69:552–558.
43. F.Malir,, M.Brndiar,, T.Roubal,, J.Severa,, P.Fixa,, J.Kacerovsky,, J.Zahradnik,, J.Osterreicher,, H.Knizek, and M.Cerna, (2001a). A study of the accumulation of ochratoxin A (OTA) in patients with chronic renal insufficiency (CHRI) in the Czech Republic. Mycotoxin Res. 17:39–44.
44. F.Malir,, T.Roubal,, M.Brndiar,, J.Osterreicher,, J.Severa,, H.Knizek,, J.Kacerovsky,, M.Tmejova,, A.M.Bebeder,, I.Baudrimont, and E.E.Creppy, (2001b). Ochratoxin A in the Czech Republic. J. Toxicol.-Toxin Rev. 20:261–274.
45. R.Manique,, A.Pena,, C.M.Lino,, J.C.Molto, and J.Manes, (2008). Ochratoxin A in the morning and afternoon portions of urine from Coimbra and Valencian populations. Toxicon. 51:1281–1287.
46. R.R.Marquardt, and A.A.Frohlich, (1992). A review of recent advances in understanding ochratoxicosis. J. Anim. Sci. 70:3968–3988.
47. E.Martlbauer,, E.Usleber, and M.Straka, (1996). Ochratoxin A im Serum eines Lehrstuhlkollektivs: 1990–1995. In: Mycotoxin Workshop, pp. 97–101. Kulmbach, Germany. Society for Mycotoxin Research.
48. M.O.Moss, (1996). Mode of formation of ochratoxin A. Food Addit. Contam. 13 Suppl: 5–9.
49. K.Munoz,, M.Blaszkewicz, and G.H.Degen, (2010). Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878:2623–2629.
50. National Research Council (NRC). (1983). Risk assessment in the Federal Government: managing the process. N.R.Council, Ed., Taylor & Francis, Washington, DC.
51. National Toxicology Program (NTP). (1989). Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). D.O.H.A.H.Services., D. o. H. a. H. Ed., Research Triangle Park (NC). National Institute of Environmental Health Sciences.
52. I.G.Nikolov,, I.N.Chernozemsky,, T.Petkova-Bocharova,, T.Vrabcheva,, I.Stojchev,, B.Bankov,, M.Castegnaro,, A.Pfohl-Leszkowicz,, S.Dragacci,, N.Day,, C.Gill,, E.Useleber,, R.Dietrich, and E.Martlbauer, (2002). Review of the cooperative studies of the national oncological centre in Bulgaria on Balkan endemic nephropathy and associated urinary tract tumors. Med. Biol. 9:119–122.
53. E.O’Brien, and D.R.Dietrich, (2005). Ochratoxin A: the continuing enigma. Crit. Rev. Toxicol. 35:33–60.
54. M.Olsen,, I.Thorup,, I.Knudsen,, J.J.Larsen,, B.Hald, and J.Olsen, (1991). Health Evaluation of Ochratoxin A in Food Products. Taylor & Francis, Copenhagen.
55. N.Ozcelik,, A.Kosar, and D.Sosal, (2001). Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol. Lett. 121:9–13.
56. D.Palli,, M.Miraglia,, C.Saieva,, G.Masala,, E.Cava,, M.Colatosti,, A.M.Corsi,, A.Russo, and C.Brera, (1999). Serum levels of ochratoxin A in healthy adults in Tuscany: Correlation with individual characteristics and between repeat measurements. Cancer Epidemiol. Biomar. Prevent. 8:265–269.
57. M.Pascale, and A.Visconti, (2000). Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high performance liquid chromatography. Mycopathologia. 152:91–95.
58. A.Pena,, M.Seifrtova,, C.Lino,, I.Silveira, and P.Solich, (2006). Estimation of ochratoxin A in Portuguese population: new data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection. Food Chem. Toxicol. 44:1449–1454.
59. J.J.Pestka, and G.S.Bondy, (1994). Mycotoxin-induced immunomodulation In: Immunotoxicology and immunopharmacology, pp. 163–182. J.H.Dean,, M.I.Luster,, A.E.Munson, and I.Kimber, Eds., Taylor & Francis, New York.
60. T.Petkova-Bocharova,, M.Castegnaro,, A.Pfohl-Leskowicz,, L.Garren,, F.Grosso,, I.Nikolov,, T.Vrabcheva,, S.Dragacci, and I.N.Chernozemsky, (2003). Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan endemic nephropathy: a one-month follow-up study. J. Agric. Food. Chem. 52:2404–2410.
61. A.Pfohl-Leszkowicz,, T.Petkova-Bocharova,, I.N.Chernozemsky, and M.Castegnaro, (2002). Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 19:282–302.
62. B.Radic,, R.Fuchs,, M.Peraica, and A.Lucic, (1997). Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol. Lett. 91:105–109.
63. A.Roth,, K.Chakor,, E.E.Creppy,, A.Kane,, R.Roschenthaler, and G.Dirheimer, (1988). Evidence for an enterohepatic circulation of ochratoxin A in mice. Toxicol. 48:293–308.
64. J.Rubert,, J.M.Soriano,, J.Manes, and C.Soler, (2011). Rapid mycotoxin analysis in human urine: a pilot study. Food Chem. Toxicol. 49:2299–2304.
65. J.Ruprich, and V.Ostry, (1993). Health risk assessment of the mycotoxin ochratoxin A to humans: Czech Republic—Brno—1991/92. Cent. Eur. J. Public Health. 1:86–93.
66. T.A.Sattler,, T.Dimitrov, and P.W.Hall, (1977). Relation between endemic (Balkan) nephropathy and urinary-tract tumours. Lancet. 1:278–280.
67. P.M.Scott, (2005). Biomarkers of human exposure to ochratoxin A. Food Addit. Contam. 22 Suppl 1:99–107.
68. M.Solfrizzo,, L.Gambacorta,, V.M.Lattanzio,, S.Powers, and A.Visconti, (2011). Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, alpha and beta-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins. Anal. Bioanal. Chem. 401:2831–2841.
69. I.Studer-Rohr,, J.Schlatter, and D.R.Dietrich, (2000). Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch. Toxicol. 74:499–510.
70. S.Voo,, D.Drugarin,, A.Biriescu,, F.Margineanu,, R.T.Olariu, and I.A.Koreck, (2002). Ochratoxin A serum levels in patients with Balkan nephropathy. Cent. Euro. J. Occup. Environ. Med. 8:178–182.
71. E.W.Wafa,, R.S.Yahya,, M.A.Sobh,, I.Eraky,, M.El-Baz,, H.A.El-Gayar,, A.M.Betbeder, and E.E.Creppy, (1998). Human ochratoxicosis and nephropathy in Egypt: a preliminary study. Hum. Exp. Toxicology. 17:124–129.
72. World Health Organization (WHO). (2002). Evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives, pp. 27–35. Taylor & Francis, Geneva.